Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013

Eurosurveillance

Volumn 18, Issue 5, 2013, Pages

  Skowronski, D M ^a,b   Janjua, N Z ^a,b   De Serres, G ^c,d,e   Dickinson, J A ^f   Winter, A L ^g   Mahmud, S M ^h,i   Sabaiduc, S ^a   Gubbay, J B ^g,j   Charest, H ^c   Petric, M ^a,b   Fonseca, K ^f,k   Van Caeseele, P ^l   Kwindt, T L ^a,b   Krajden, M ^a,b   Eshaghi, A ^g   Li, Y ^i,m  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c National Institute of Health of Quebec   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g PUBLIC HEALTH ONTARIO   (Canada)

^h WINNIPEG REGIONAL HEALTH AUTHORITY   (Canada)

ⁱ UNIVERSITY OF MANITOBA   (Canada)

^j UNIVERSITY OF TORONTO   (Canada)

^k Alberta Provincial Laboratory   (Canada)

^l CADHAM PROVINCIAL LABORATORY   (Canada)

^m PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HEMAGGLUTININ; INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANADA; CHILD; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE MUTATION; GENETIC TRAIT; HEMAGGLUTINATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); MAJOR CLINICAL STUDY; MALE; PHYLOGENETIC TREE; PRESCHOOL CHILD; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SENSITIVITY ANALYSIS;

EID: 84873302726     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.18.05.20394-en     Document Type: Article

References (21)

1. Public Health Agency of Canada. FluWatch. [Accessed 26 Jan 2013]. Available from: http://www.phac-aspc.gc.ca/fluwatch/12-13/index-eng.php
2. Centers for Disease Control and Prevention (CDC). FluView. Atlanta, GA: CDC. [Accessed 26 Jan 2013]. Available from: http://www.cdc.gov/flu/weekly/
3. World Health Organization (WHO). WHO recommendations on the composition of influenza virus vaccines. Geneva: WHO. [Accessed 11 Jan 2013]. Available from:http://www.who.int/influenza/vaccines/virus/recommendations/en/index.html
4. Janjua NZ, Skowronski DM, De Serres G, Winter A-L, Dickinson JA, Mahmud SM, et al. Component-specific estimates of 2011-12 influenza vaccine effectiveness based on the Canadian sentinel surveillance system. Tenth Canadian Immunization Conference, 3-5 December 2012; Vancouver, British Columbia, Canada. Poster number P-001.
5. Skowronski DM, Gilbert M, Tweed SA, Petric M, Li Y, Mak A, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep. 2005;31:181-91. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/dr3118a-eng.php
6. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007;25(15):2842-51.
7. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis. 2009;199(2):168-79.
8. Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, et al. Estimates of influenza vaccine effectiveness for 2007-08 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis. 2012;205(12):1858-68.
9. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258.
10. Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, et al. Effectiveness of AS03-adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ. 2011;342:c7297. Doi:10.1136/bmj.c7297.
11. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis. 2012;55(3):332-42.
12. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science. 1999; 286(5446):1921-5.
13. National Advisory Committee on Immunization. Statement on seasonal influenza vaccine for 2012-2013. Can Commun Dis Rep. 2012;38:1-36. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-2/index-eng.php
14. Statistics Canada. Influenza immunization, less than one year ago by age group and sex (percent). Ottawa: Statistics Canada. [Accessed 30 Jan 2013]. Available from: http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/health101b-eng.htm
15. Broemeling AM, Watson DE, Prebtani F. Population patterns of chronic health conditions, co-morbidity and healthcare use in Canada: implications for policy and practice. Healthc Q. 2008;11(3):70-6.
16. European Centre for Disease Prevention and Control (ECDC). Influenza virus characterization. Summary Europe, November 2012. Surveillance report. Stockholm: ECDC. Available from:http://ecdc.europa.eu/en/publications/Publications/influenza-virus-characterisation-CNRL-dec-2012.pdf
17. Centers for Disease Control and Prevention (CDC). Early estimates of seasonal influenza vaccine effectiveness-United States, January 2013. MMWR Morb Mortal Wkly Rep. 2013;62:32-5. Available from:http://www.cdc.gov/MMWr/preview/mmwrhtml/mm62e0111a1.htm?s_cid=mm62e0111a1_w
18. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis. 2012; 12(1):36-44.
19. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737-71.
20. Smith DJ, Lapedes AS, deJong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, et al. Mapping the antigenic and genetic evolution of influenza virus. Science. 2004;305(5682):371-6.
21. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA. 1999;96(24):14001-6.